• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

表面活性蛋白A和D通过不同机制结合CD14。

Surfactant proteins A and D bind CD14 by different mechanisms.

作者信息

Sano H, Chiba H, Iwaki D, Sohma H, Voelker D R, Kuroki Y

机构信息

Department of Biochemistry, Sapporo Medical University School of Medicine, Sapporo, Japan.

出版信息

J Biol Chem. 2000 Jul 21;275(29):22442-51. doi: 10.1074/jbc.M001107200.

DOI:10.1074/jbc.M001107200
PMID:10801802
Abstract

Surfactant proteins A (SP-A) and D (SP-D) are lung collectins that are constituents of the innate immune system of the lung. Recent evidence (Sano, H., Sohma, H., Muta, T., Nomura, S., Voelker, D. R., and Kuroki, Y. (1999) J. Immunol. 163, 387-395) demonstrates that SP-A modulates lipopolysaccharide (LPS)-induced cellular responses by direct interaction with CD14. In this report we examined the structural elements of the lung collectins involved in CD14 recognition and the consequences for CD14/LPS interaction. Rat SP-A and SP-D bound CD14 in a concentration-dependent manner. Mannose and EDTA inhibited SP-D binding to CD14 but did not decrease SP-A binding. The SP-A binding to CD14 was completely blocked by a monoclonal antibody that binds to the SP-A neck domain but only partially blocked by an antibody that binds to the SP-A lectin domain. SP-A but not SP-D bound to deglycosylated CD14. SP-D decreased CD14 binding to both smooth and rough LPS, whereas SP-A enhanced CD14 binding to rough LPS and inhibited binding to smooth LPS. SP-A also altered the migration profile of LPS on a sucrose density gradient in the presence of CD14. From these results, we conclude that 1) lung collectins bind CD14, 2) the SP-A neck domain and SP-D lectin domain participate in CD14 binding, 3) SP-A recognizes a peptide component and SP-D recognizes a carbohydrate moiety of CD14, and 4) lung collectins alter LPS/CD14 interactions.

摘要

表面活性蛋白A(SP-A)和表面活性蛋白D(SP-D)是肺凝集素,是肺固有免疫系统的组成部分。最近的证据(佐野浩、宗间浩、武田哲、野村幸、沃尔克·D·R和黑木洋(1999年)《免疫学杂志》163卷,387 - 395页)表明,SP-A通过与CD14直接相互作用来调节脂多糖(LPS)诱导的细胞反应。在本报告中,我们研究了参与CD14识别的肺凝集素的结构元件以及对CD14/LPS相互作用的影响。大鼠SP-A和SP-D以浓度依赖的方式结合CD14。甘露糖和乙二胺四乙酸(EDTA)抑制SP-D与CD14的结合,但不降低SP-A的结合。与SP-A颈部结构域结合的单克隆抗体完全阻断了SP-A与CD14的结合,但与SP-A凝集素结构域结合的抗体仅部分阻断了这种结合。SP-A而非SP-D与去糖基化的CD14结合。SP-D降低了CD14与光滑型和粗糙型LPS的结合,而SP-A增强了CD14与粗糙型LPS的结合并抑制了与光滑型LPS的结合。在存在CD14的情况下,SP-A还改变了LPS在蔗糖密度梯度上的迁移图谱。从这些结果中,我们得出以下结论:1)肺凝集素结合CD14;2)SP-A颈部结构域和SP-D凝集素结构域参与CD14的结合;3)SP-A识别CD14的肽成分,SP-D识别CD14的碳水化合物部分;4)肺凝集素改变LPS/CD14相互作用。

相似文献

1
Surfactant proteins A and D bind CD14 by different mechanisms.表面活性蛋白A和D通过不同机制结合CD14。
J Biol Chem. 2000 Jul 21;275(29):22442-51. doi: 10.1074/jbc.M001107200.
2
Rat mannose-binding protein a binds CD14.大鼠甘露糖结合蛋白a与CD14结合。
Infect Immun. 2001 Mar;69(3):1587-92. doi: 10.1128/IAI.69.3.1587-1592.2001.
3
Pulmonary surfactant protein A modulates the cellular response to smooth and rough lipopolysaccharides by interaction with CD14.肺表面活性蛋白A通过与CD14相互作用调节细胞对光滑型和粗糙型脂多糖的反应。
J Immunol. 1999 Jul 1;163(1):387-95.
4
Chimeras of surfactant proteins A and D identify the carbohydrate recognition domains as essential for phospholipid interaction.表面活性蛋白A和D的嵌合体表明,碳水化合物识别结构域对于磷脂相互作用至关重要。
J Biol Chem. 1994 Nov 25;269(47):29785-92.
5
Functional roles and structural analysis of lung collectins SP-A and SP-D.
Biol Neonate. 1999 Jun;76 Suppl 1:19-21. doi: 10.1159/000047042.
6
Interaction of human lung surfactant proteins A and D with mite (Dermatophagoides pteronyssinus) allergens.人肺表面活性物质蛋白A和D与螨(屋尘螨)过敏原的相互作用。
Clin Exp Immunol. 1996 Nov;106(2):367-73. doi: 10.1046/j.1365-2249.1996.d01-838.x.
7
Surfactant protein A binds to the fusion glycoprotein of respiratory syncytial virus and neutralizes virion infectivity.表面活性蛋白A与呼吸道合胞病毒的融合糖蛋白结合,并中和病毒体的感染性。
J Infect Dis. 1999 Dec;180(6):2009-13. doi: 10.1086/315134.
8
Surfactant protein A differentially regulates IFN-gamma- and LPS-induced nitrite production by rat alveolar macrophages.表面活性蛋白A对大鼠肺泡巨噬细胞中干扰素-γ和脂多糖诱导的亚硝酸盐生成具有不同的调节作用。
Am J Respir Cell Mol Biol. 2000 Dec;23(6):772-9. doi: 10.1165/ajrcmb.23.6.4083.
9
Surfactant protein a inhibits lipopolysaccharide-induced immune cell activation by preventing the interaction of lipopolysaccharide with lipopolysaccharide-binding protein.表面活性蛋白A通过阻止脂多糖与脂多糖结合蛋白的相互作用来抑制脂多糖诱导的免疫细胞激活。
Am J Respir Cell Mol Biol. 2002 Sep;27(3):353-60. doi: 10.1165/rcmb.4812.
10
Importance of the carboxy-terminal 25 amino acid residues of lung collectins in interactions with lipids and alveolar type II cells.肺凝集素羧基末端25个氨基酸残基在与脂质和肺泡II型细胞相互作用中的重要性。
Biochemistry. 2000 Feb 8;39(5):1059-66. doi: 10.1021/bi9917939.

引用本文的文献

1
Absence of c-Maf and IL-10 enables type I IFN enhancement of innate responses to LPS in alveolar macrophages.c-Maf和白细胞介素-10的缺失使得I型干扰素增强肺泡巨噬细胞对脂多糖的天然免疫反应。
J Immunol. 2025 Mar 3;214(3):551-64. doi: 10.1093/jimmun/vkae029.
2
Revisiting surfactant protein D: an immune surveillance molecule bridging innate and adaptive immunity.重新审视表面活性蛋白D:一种连接固有免疫和适应性免疫的免疫监视分子。
Front Immunol. 2024 Dec 17;15:1491175. doi: 10.3389/fimmu.2024.1491175. eCollection 2024.
3
Intravenous surfactant protein D inhibits lipopolysaccharide-induced systemic inflammation.
静脉注射表面活性蛋白 D 可抑制脂多糖诱导的全身炎症。
Ann Anat. 2023 Apr;247:152048. doi: 10.1016/j.aanat.2023.152048. Epub 2023 Jan 20.
4
Pulmonary surfactant as a versatile biomaterial to fight COVID-19.肺表面活性剂作为一种多功能生物材料对抗 COVID-19。
J Control Release. 2022 Feb;342:170-188. doi: 10.1016/j.jconrel.2021.11.023. Epub 2021 Nov 20.
5
Surfactant Proteins A/D-CD14 on Alveolar Macrophages Is a Common Pathway Associated With Phagocytosis of Nanomaterials and Cytokine Production.肺泡巨噬细胞表面的表面活性剂蛋白 A/D-CD14 是与纳米材料吞噬和细胞因子产生相关的共同途径。
Front Immunol. 2021 Oct 27;12:758941. doi: 10.3389/fimmu.2021.758941. eCollection 2021.
6
Repurpose but also (nano)-reformulate! The potential role of nanomedicine in the battle against SARS-CoV2.重新定位,也要(纳米)重塑!纳米医学在抗击 SARS-CoV2 中的潜在作用。
J Control Release. 2021 Sep 10;337:258-284. doi: 10.1016/j.jconrel.2021.07.028. Epub 2021 Jul 20.
7
Targeting TLR4 Signaling to Blunt Viral-Mediated Acute Lung Injury.靶向 TLR4 信号通路以减轻病毒介导的急性肺损伤。
Front Immunol. 2021 Jul 2;12:705080. doi: 10.3389/fimmu.2021.705080. eCollection 2021.
8
Surfactant protein D and bronchopulmonary dysplasia: a new way to approach an old problem.表面活性蛋白 D 与支气管肺发育不良:一个解决老问题的新方法。
Respir Res. 2021 May 8;22(1):141. doi: 10.1186/s12931-021-01738-4.
9
SP-A and SP-D: Dual Functioning Immune Molecules With Antiviral and Immunomodulatory Properties.表面活性蛋白 A 和 D:具有抗病毒和免疫调节特性的双重功能免疫分子。
Front Immunol. 2021 Jan 19;11:622598. doi: 10.3389/fimmu.2020.622598. eCollection 2020.
10
Surfactant Protein D Recognizes Multiple Fungal Ligands: A Key Step to Initiate and Intensify the Anti-fungal Host Defense.表面活性蛋白D识别多种真菌配体:启动和增强抗真菌宿主防御的关键步骤。
Front Cell Infect Microbiol. 2020 May 29;10:229. doi: 10.3389/fcimb.2020.00229. eCollection 2020.